Janice Wang MD
Critical Care Medicine, Pleural Disease, Sleep Medicine
Instructor, Medicine, Hofstra North Shore-LIJ
Join to View Full Profile
410 Lakeville RdSte 105New Hyde Park, NY 11042
Phone+1 516-465-5400
Fax+1 516-465-5454
Dr. Wang is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Zucker School of Medicine at Hofstra/NorthwellFellowship, Sleep Medicine, 2011 - 2013- Zucker School of Medicine at Hofstra/NorthwellFellowship, Pulmonary Disease and Critical Care Medicine, 2009 - 2011
- Zucker School of Medicine at Hofstra/NorthwellResidency, Internal Medicine, 2006 - 2009
State University of New York Downstate Medical Center College of MedicineClass of 2006
Certifications & Licensure
NY State Medical License 2007 - 2027
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Critical Care Medicine
- American Board of Internal Medicine Pulmonary Disease
- American Board of Internal Medicine Sleep Medicine
Publications & Presentations
PubMed
- 5 citationsMUlticenter STudy of tissue plasminogen activator (alteplase) use in COVID-19 severe respiratory failure (MUST COVID): A retrospective cohort study.Christopher D Barrett, Hunter B Moore, Ernest E Moore, Dudley Benjamin Christie 3rd, Sarah Orfanos
Research and Practice in Thrombosis and Haemostasis. 2022-02-01 - 294 citationsEfficacy and Safety of Therapeutic-Dose Heparin vs Standard Prophylactic or Intermediate-Dose Heparins for Thromboprophylaxis in High-risk Hospitalized Patients With C...Alex C. Spyropoulos, Mark Goldin, Dimitrios Giannis, Wassim Diab, Janice Wang
JAMA Internal Medicine. 2021-10-07 - 8 citationsTreatment-Dose LMWH versus Prophylactic/Intermediate Dose Heparins in High-Risk COVID-19 Inpatients: Rationale and Design of the HEP-COVID Trial.Mark Goldin, Dimitrios Giannis, Wassim Diab, Janice Wang, Sameer Khanijo
Thrombosis and Haemostasis. 2021-04-06
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
